The tribulations of community-based trials

January 2004
CMAJ: Canadian Medical Association Journal;1/6/2004, Vol. 170 Issue 1, p33
Academic Journal
Focuses on the trend of clinical trials sponsored by the pharmaceutical industry in Canada migrating from academic settings into the community. Challenges posed to physicians and the medical profession; Impact on issues of conflict of interest, patient safety and public interest; Percentage of clinical trials conducted in Canada in 2002 that were industry sponsored.


Related Articles

  • Working the Pharmaceutical PIPELINE Databases. Breton, Tara // Searcher;Sep2003, Vol. 11 Issue 8, p32 

    Presents information on how to use a pharmaceutical pipeline database. Definition of a pipeline; Levels of a pharmaceutical pipeline; Information on the actual pipeline process.

  • Optimizing Phase III Trials. McLennan, Derek; Foley, Patrick // European Pharmaceutical Executive;Feb/Mar2007, p40 

    The article discusses some of the pitfalls inherent in the Phase III planning process and proposes some solutions for getting it right. The authors suggests that developing successful Phase III clinical trial strategies in today's European pharmaceutical marketing environment requires a balance...

  • Calendar of Events.  // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p80 

    Presents a calendar of seminars, meetings, and other events of interest to pharmaceutical and clinical research professionals that are scheduled for the months of September 2005 and October 2005. "Pharmacy Aspects of Clinical Trials"; "Pharma Performance Metrics & Benchmarking Summit"; "Impact...

  • Should paediatricians support the European Paediatric Clinical Trials Register? Sammons, H. M.; Naylor, C.; Choonara, I.; Pandolfini, C.; Bonati, M. // Archives of Disease in Childhood;Jun2005, Vol. 90 Issue 6, p559 

    The article discusses the need of pediatricians' support for European Paediatric Clinical Trials Register. A European legislation is currently being proposed that will provide a financial incentive to the pharmaceutical industry to study medicines in Europe. The proposal has been prepared by the...

  • How Do Pharmaceutical Companies Approach Data from Sexual Health Studies for Regulatory Agencies? Dilleen, Maria; Haughie, Scott // Annual Review of Sex Research;2005, Vol. 16 Issue 1, p53 

    The article outlines the importance of statistical input into clinical trial research in the pharmaceutical industry an in interactions with regulatory agencies. It focuses on the role of statisticians in projects on sexual health during the 2nd and 3rd phases of clinical trials that are...

  • China captivates the clinical trial sector. Kermani, Faiz // Pharmaceutical Technology Europe;May2008, Vol. 20 Issue 5, p12 

    The author focuses on the increasing interest of several pharmaceutical companies to outsource their clinical trials to China. Consulting firm AT Kearney claimed that the country is the most attractive, low-cost location to run clinical trials outside the U.S. in 2007. The author explains that...

  • CLINICAL TRIALS NEWS.  // Applied Clinical Trials;Apr2006, Vol. 15 Issue 4, p22 

    The article reports on developments relevant to clinical trials and drug development in the U.S. as of April 2006. Key issues discussed include the range of new drugs tested during the clinical trials, the pharmaceutical companies involved in the clinical trial process and the range of ailments...

  • Calendar.  // Pharmaceutical Technology;Oct2004, Vol. 28 Issue 10, p224 

    The article presents information about various meetings related to pharmaceutical industry. "Validation Week-Annual Meeting," will take place in October 2004 in Philadelphia, Pennsylvania. "AAPS: Annual Meeting and Exposition," will take place in November 2004 in Baltimore. "International...

  • Expert offers strategies for survival in today's CR environment.  // Clinical Trials Administrator;Jun2008, Vol. 6 Issue 6, p70 

    The article offers suggestions to clinical trial (CT) investigators and professionals on handling the challenges in the clinical research industry. Investing in training program, as suggested, will likely helped familiarized the staff with the CT site's standard operating procedures. A careful...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics